drugset / Trial / NCT02101164
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
RandomizedCrossoverOpen-label
Summary
This study will estimate the total time for the preparation and administration of denosumab and the total time for the preparation and administration of pamidronate.
Timeline
- Start
- 2014-11
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Denosumab | Monoclonal antibody | 120 mg | Subcutaneous |
| Comparator | Pamidronate | Small molecule | 90 mg | Intravenous |